These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4361873)

  • 1. Carbon-13 NMR studies of peptide hormones and their components.
    Smith IC; Deslauriers R; Saitô H; Walter R; Garrigou-Lagrange C; McGregor H; Sarantakis D
    Ann N Y Acad Sci; 1973 Dec; 222():597-627. PubMed ID: 4361873
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformational mobility of the pyrrolidine ring of proline in peptides and peptide hormones as manifest in carbon 13 spin-lattice relaxation times.
    Deslauriers R; Smith IC; Walter R
    J Biol Chem; 1974 Nov; 249(21):7006-10. PubMed ID: 4371430
    [No Abstract]   [Full Text] [Related]  

  • 3. 13C nuclear magnetic resonance studies of the conformation of the X-pro bond in the oligopeptide hormones, thyrotropin-releasing hormone, luteinizing hormone-releasing factor, angiotensin and melanocyte-stimulating hormone release-inhibiting factor.
    Deslauriers R; Walter R; Smith IC
    Biochem Biophys Res Commun; 1973 Jul; 53(1):244-50. PubMed ID: 4354931
    [No Abstract]   [Full Text] [Related]  

  • 4. Intramolecular motion in peptide determined by 13C NMR: a spin-lattice relaxation time-study on MSH-release-inhibiting factor.
    Deslauriers R; Walter R; Smith IC
    FEBS Lett; 1973 Nov; 37(1):27-32. PubMed ID: 4585031
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
    Castensson S; Sievertsson H; Lindeke B; Sum CY
    FEBS Lett; 1974 Aug; 44(1):101-5. PubMed ID: 4212370
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivation of melanocyte-stimulating hormone release-inhibiting factor by a manganese-stimulated bovine brain aminopeptidase.
    Simmons WH; Brecher AS
    J Biol Chem; 1973 Aug; 248(16):5780-4. PubMed ID: 4353274
    [No Abstract]   [Full Text] [Related]  

  • 7. Location of hypothalamic control centres and nature of regulatory hormones.
    Sandow J
    Clin Endocrinol Metab; 1977 Mar; 6(1):155-65. PubMed ID: 408064
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectral assignment and conformational analysis of cyclic peptides by carbon-13 nuclear magnetic resonance.
    Lyerla JR; Freedman MH
    J Biol Chem; 1972 Dec; 247(24):8183-92. PubMed ID: 4640941
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation.
    Walter R; Griffiths EC; Hooper KC
    Brain Res; 1973 Oct; 60(2):449-57. PubMed ID: 4587290
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbon-13 spin-lattice relaxation studies of intramolecular motion in lysine and a series of oligolysines.
    Saito H; Smith IC
    Arch Biochem Biophys; 1974 Aug; 163(2):699-704. PubMed ID: 4369827
    [No Abstract]   [Full Text] [Related]  

  • 11. MSH-release inhibiting factors: recent studies.
    Kastin AJ; Plotnikoff NP; Viosca S; Anderson MS; Schally AV
    Yale J Biol Med; 1973 Dec; 46(5):617-22. PubMed ID: 4591788
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurohypophyseal hormones as precursors of hypophysiotropic hormones.
    Schwartz IL; Walter R
    Isr J Med Sci; 1974 Oct; 10(10):1288-93. PubMed ID: 4373416
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroendocrine relationships.
    Van Loon GR; Kragt CL
    Prog Neurol Psychiatry; 1971; 26():261-310. PubMed ID: 4363627
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and structure of hypothalamic MSH release-inhibition hormone.
    Nair RM; Kastin AJ; Schally AV
    Biochem Biophys Res Commun; 1971 Jun; 43(6):1376-81. PubMed ID: 4398196
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypothalamic releasing factors and Parkinson disease.
    Chase TN; Woods AC; Lipton MA; Morris CE
    Arch Neurol; 1974 Jul; 31(1):55-6. PubMed ID: 4209275
    [No Abstract]   [Full Text] [Related]  

  • 16. Conformational studies of oxytocin, lysine vasopressin, arginine vasopressin, and arginine vasotocin by carbon-13 nuclear magnetic resonance spectroscopy.
    Walter R; Prasad KU; Deslauriers R; Smith IC
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2086-90. PubMed ID: 4516207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic control of anterior pituitary hormone secretion--characterized hypothalamic-hypophysiotropic peptides.
    Grant GF; Vale W
    Curr Top Exp Endocrinol; 1974; 2():37-72. PubMed ID: 4208407
    [No Abstract]   [Full Text] [Related]  

  • 18. On the presence in hog hypothalamus of 3-corticotropin releasing factor, alpha- and beta-melanocyte stimulating hormones, adrenocorticotropin, lysine-vasopressin and oxytocin.
    GUILLEMIN R; SCHALLY AV; LIPSCOMB HS; ANDERSEN RN; LONG JM
    Endocrinology; 1962 Apr; 70():471-7. PubMed ID: 13902822
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbon-13 nuclear magnetic resonance studies on thyrotropin-releasing factor and related peptides.
    Deslauriers R; Garrigou-Lagrange C; Bellocq AM; Smith UC
    FEBS Lett; 1973 Apr; 31(1):59-66. PubMed ID: 4196901
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothalamic regulatory hormones.
    Schally AV; Coy DH; Meyers CA
    Annu Rev Biochem; 1978; 47():89-128. PubMed ID: 28075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.